Effect of Ostokhodus Alavi capsule on students concentration.

Effects of an Iranian traditional medicine product (Ostokhodus Alavi capsule) on the cognitive performance of adolescent female students in Yazd city

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190921044827N1

Enrollment

Registered

2020-04-06

Start date

2019-10-21

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive function.

Interventions

Intervention 1: Intervention group:Ostokhodus Alavi capsule, Contents: avandula spp., Anacyclus pyrethrum, Polypodium vulgare, Cuscuta spp, Paeonia officinalis, Vitis vinifera, honey, Dose: a 250 mg c

Eligibility

Sex/Gender

Female

Age

16 Years to 17 Years

Inclusion criteria

Inclusion criteria: Healthy 16 to 17 years old girls acknowledgment of parents and students

Exclusion criteria

Exclusion criteria: Diagnosed with sever depression or anxiety or stress Diagnosed with psychological disorders that interfere with cognition function Low IQ(Low grade in mathematics, science and literature courses) Consumption of herbal or chemical drugs on cognition function at the beginning of the study Sever hearing or movement impairment that interfere with passing the PASAT study

Design outcomes

Primary

Measure	Time frame
Mental health. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: Paced Auditory serial addition Test(PASAT).;Average respond time. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Sustained attention. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Mental fatigue. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Sputum cortisol level. Timepoint: Beginning of the study, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: ELISA Kit.	—

Measure

Time frame

Mental health. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: Paced Auditory serial addition Test(PASAT).;Average respond time. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Sustained attention. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Mental fatigue. Timepoint: Beginning of the study, 3 weeks, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: PASAT test.;Sputum cortisol level. Timepoint: Beginning of the study, 6 weeks and 10 weeks from the beginning of the study. Method of measurement: ELISA Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane Tefagh

Shahid Beheshti University of Medical Sciences

s.tefagh@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026